coronavirus vaccine developed severe neurological symptoms that prompted a pause in testing, a spokesman for drugmaker AstraZeneca said Thursday.The study participant in late-stage testing reported symptoms consistent with transverse myelitis, a rare inflammation of the spinal cord, said company spokesman Matthew Kent.
AstraZeneca expects coronavirus vaccine result by year-end if trials resume soon “We don’t know if it is (transverse myelitis),” Kent said.
Read more on globalnews.ca